Recent Finacing
Recent Raise
Circle Pharma develops intrinsically cell‑permeable macrocycles via structure‑based computational design and synthetic chemistry for oral and other delivery routes, targeting intracellular protein–protein interactions, notably cyclins A/E in cancer.
